Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
29.01.2016 17:35:00

Arkema Has Decided Not to Exercise Its Option to Increase Its Rights to Acrylics Capacities in China

Regulatory News:

Arkema (Paris:AKE) had an option, until early 2016, to increase its stake in Taixing Sunke Chemicals, a production joint venture which owns and operates acrylic acid and butyl acrylate production units in Taixing, China, and therefore access an additional 160,000 tons per year acrylic acid capacity.

As the financial terms of the option no longer reflect current market conditions for acrylics in China, Arkema has decided not to exercise this option.

Therefore, Arkema keeps its initial rights to acrylic acid capacities thus supporting the development of its downstream acrylic activities in Asia and its customers’ growth in the region.

In line with its strategy to further strengthen its High Performance Materials segment, the Group could allocate part of the unused funds to make bolt-on acquisitions.

A designer of materials and innovative solutions, Arkema shapes materials and creates new uses that accelerate customer performance. Our balanced business portfolio spans high-performance materials, industrial specialties and coating solutions. Our globally recognized brands are ranked among the leaders in the markets we serve. Reporting annual sales of €7.5 billion in 2014, we employ approximately 19,200 people worldwide and operate in close to 50 countries. We are committed to active engagement with all our stakeholders. Our research centers in North America, France and Asia concentrate on advances in lightweight materials, renewable feedstocks, energy generation and storage, water treatment, electronics and 3D printing. For the latest, visit www.arkema.com.

Arkema
420, rue d’Estienne d’Orves – F-92705 COLOMBES Cedex – France
Standard : +33 (0)1 49 00 80 80 – Fax : +33 (0)1 49 00 83 96
Société anonyme au capital de 728 226 950 euros – 445 074 685 RCS Nanterre
arkema.com

Analysen zu ArkemaAct.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ArkemaAct. 74,35 -0,67% ArkemaAct.